Psychotropic drug

About: Psychotropic drug is a research topic. Over the lifetime, 2309 publications have been published within this topic receiving 54070 citations.

Psychotropic drug initiation during the first diagnosis and the active treatment phase of B cell non-Hodgkin’s lymphoma: a cohort study of the French national health insurance database

Abstract: Patients with B cell non-Hodgkin’s lymphomas (B-NHLs) are known to be at risk of developing psychological disorders. The aims of this study were to measure the incidence of psychotropic drug use during the diagnosis and the active treatment phase in comparison with controls from the general population, and to identify factors associated with this use. B-NHL patients were selected through the French national health insurance database in the Midi-Pyrenees region (southwestern France) from January 1, 2011, to April 31, 2013. Patients with a previous history of B-NHL and/or psychotropic drug treatment were excluded. Among 745 newly diagnosed B-NHL patients, psychotropic treatment was initiated in 31.5 % (95 % CI [28.1–34.9]), compared to 7.6 % (95 % CI [7.57–7.64]) in the general population during the same period. This incidence was comparable in colorectal cancer patients (33.5 %) but higher than that in patients with myocardial infarction (23.5 %) or with a first knee replacement surgery (22.4 %). Anxiolytics and hypnotics were the most frequently used drugs. Median duration of treatment was 37 days for anxiolytics and 58 days for hypnotics, with 20.8 % of patients remaining under treatment at 8 months. Factors associated with psychotropic drug initiation were young age, health care consumption in the year before diagnosis, and initial care at a university hospital. The high rate of psychotropic drug initiation reflects a high level of anxiety at the initial phase of B-NHL patients’ trajectory. This pharmacoepidemiological study reveals inappropriate use in some patients, which should now be investigated in lymphoma survivorship.

Dispensações de psicotrópicos anorexígenos no município de Juiz de Fora, Minas Gerais, Brasil

Abstract: Obesity is a serious public health issue of epidemic proportions. Although drug therapy is one of the therapeutic approaches, it should be preceded by a change in eating habits along with regular exercise. This study assessed prescription of such drugs in 2009, in Juiz de Fora, Minas Gerais, Brazil. Data were collected from consumption bulletins sent monthly to the municipal sanitary surveillance agency (VISA), and from the Brazilian National Management System of Controlled Products. Of the 7,759 notifications assessed, 93.3% were dispensed by prescription pharmacies and 6.7% by drugstores. Of that total, 55.4% were for amphepramone, 33.1% for femproporex, and 11.5% for mazindol. The three drugs had a larger consumption rate in the municipality (daily defined dose/1,000 inhabitants/day) than in the country as a whole, during the period under study. The professional with the highest prescription rate was responsible for 3,535 prescriptions. All of these were dispensed by prescription pharmacies, a single outlet being responsible for 99.5% of these prescriptions. This scenario shows that anorectic psychotropic drug prescription is a relevant public health issue and the criteria for monitoring the prescription and consumption of these drugs should be re-evaluated.

Sleep medication in acute psychiatric illness: patient's knowledge and prescription patterns in New Zealand.

Abstract: Adult patients (N = 100) being treated for acute psychiatric illness were interviewed about their sleep problems and attitudes toward available treatments. Most (74%) were using at least one prescribed psychotropic drug with hypnotic or sedative effects. Participants prescribed three or more drugs were less likely to name them correctly compared with those prescribed less. One quarter (24%) did not know that they were on a hypnosedative; more than half of those not prescribed a hypnosedative thought they were. Most participants found their medication effective; however, 54% wished to discontinue it. Two fifths of zopiclone users had been using it for more than 12 months. Although subjective sleep problems are very common in this patient group, they have limited accurate knowledge about their medication treatments. Many want to try alternative nonpharmacological ways to manage their sleep problems.

Psychotropic Drug Information Handbook

Abstract: Psychotropic Drug Information Handbook , Psychotropic Drug Information Handbook , کتابخانه مرکزی دانشگاه علوم پزشکی تهران

Countertransference aspects of pharmacotherapy in the treatment of schizophrenia.

Abstract: Emphasis is placed on largely unconscious aspects of the therapeutic relationship which determine the inappropriate or untimely use of psychotropic drugs, particularly on the therapist's response to the regressive modes of relating and sharing emotional experience which characterize therapeutic work with schizophrenic patients. Case examples illustrate the use of drugs to establish interpersonal boundaries, to disavow frightening feelings within the self, and to renounce forbidden regressive pleasures-thus defending against the regressive pull of the developing symbiotic relationship. The effect of postpsychotic depression on the therapeutic relationship is explored with regard to the dynamics of psychotropic drug usage in treatment.